Authors:
KLINGER W
LUPP A
KARGE E
OELSCHLAGER H
ROTHLEY D
DANZ M
LINSS W
LOBEL S
DEUFEL T
MULLER M
KLINGER M
KUHNEL W
Citation: W. Klinger et al., CIPROFIBRATE-RACEMATE AND ENANTIOMERS - EFFECTS OF A 4-WEEK TREATMENTON MALE INBRED FISCHER RATS - A BIOCHEMICAL AND MORPHOLOGICAL-STUDY, Experimental and toxicologic pathology, 50(4-6), 1998, pp. 301-314
Authors:
OELSCHLAGER H
ROTHLEY D
KLINGER W
KARGE E
VOGELSANG H
Citation: H. Oelschlager et al., CHROMATOGRAPHIC RESOLUTION OF CIPROFIBRATE AND INTERACTION OF THE RACEMATE AND BOTH ENANTIOMERS WITH RAT-LIVER MICROSOMES IN-VITRO, Experimental and toxicologic pathology, 50(4-6), 1998, pp. 323-329
Authors:
OELSCHLAGER H
KLINGER W
ROTHLEY D
SEELING A
BOCKHARD H
HOFMANN B
MACHTS H
RIEDERER H
RACKUR H
Citation: H. Oelschlager et al., CLEAVAGE ACID BIOTRANSFORMATION OF THE CENTRALLY ACTING MUSCLE-RELAXANT CHLORMEZANONE, Die Pharmazie, 53(9), 1998, pp. 620-624
Citation: M. Abukhurmah et al., FORMATION OF BRENZCATECHINE DERIVATIVES BY REDUCTION OF 6-OXO-MORPHINDERIVATIVES AT MERCURY-ELECTRODES, Die Pharmazie, 53(8), 1998, pp. 524-528
Citation: H. Oelschlager et H. Knoth, POLAROGRAPHIC ANALYSIS OF OMEPRAZOLE FORM ULATIONS, PART 38 - DRUG ANALYSIS USING POLAROGRAPHIC METHODS, Die Pharmazie, 53(4), 1998, pp. 242-244
Citation: H. Oelschlager et M. Abukhurmah, BEHAVIOR OF NALOXON [(-)-17-ALLYL-4,5-ALP HA-EPOXY-3,14-HYDROXYMORPHINAN-6-ONE] AT THE DROPPING MERCURY-ELECTRODE, Die Pharmazie, 53(3), 1998, pp. 164-168
Citation: M. Abukhurmah et H. Oelschlager, ELECTROANALYSIS AND MECHANISM OF THE REDU CTION OF THE ANTIPSYCHOTIC DRUG TIMELOTEM, ,4A,5-HEXAHYDRO-PYRAZINO[1,2-A][1,4]BENZODIAZEPIN, AT THE DROPPING MERCURY-ELECTRODE, Die Pharmazie, 53(1), 1998, pp. 32-38
Authors:
KLINGER W
OELSCHLAGER H
KARGE E
ROTHLEY D
Citation: W. Klinger et al., INTERACTION OF CHLORMEZANONE WITH RAT-LIVER MICROSOMES AND ITS DEGRADATION, European journal of drug metabolism and pharmacokinetics, 22(2), 1997, pp. 165-171
Citation: H. Knoth et al., ELECTROCHEMICAL-BEHAVIOR OF THE PROTON PU MP INHIBITOR OMEPRAZOL 5-DIMETHYL-2-PRYIDYL)METHYL]SULFINYL)BENZIMIDAZOL), Die Pharmazie, 52(9), 1997, pp. 686-691
Citation: M. Abukhurmah et al., ELECTROANALYSIS AND MECHANISM OF THE REDUCTION OF LOPIRAZEPAM RO-1,2-DIHYDRO-1H-PYRIDO[3,2-E]-1,4-DIAZEPIN-2-ON] AT THE DROPPING MERCURY-ELECTRODE, Die Pharmazie, 52(10), 1997, pp. 775-780
Citation: C. Kohl et al., IDENTIFICATION OF DRUG GLUCURONIDES IN HUMAN URINE BY RP-HPLC AFTER DERIVATIZATION, Journal of pharmaceutical and biomedical analysis, 12(2), 1994, pp. 249-254
Citation: H. Oelschlager et al., PHARMACOKINETICS OF HYPOLIPIDEMIC AGENTS, X(- 2ND CONTRIBUTION TO THEPROBLEM OF THE DEHALOGENATION OF THE LIPID-LOWERING AGENT CIPROFIBRATE() ), Archiv der pharmazie, 327(4), 1994, pp. 261-265
Citation: H. Oelschlager et W. Schmidt, FRANKFURT SHIFT .2. FURTHER CONTRIBUTIONS ON THE INTRAMOLECULAR SHIFTOF N-OXIDES OF TERTIARY CYCLOALKYLAMINES TO LACTAMS (FRANKFURT SHIFT), Archiv der pharmazie, 327(3), 1994, pp. 163-167
Authors:
HEIM W
OELSCHLAGER H
KREUTER J
MULLEROERLINGHAUSEN B
Citation: W. Heim et al., LIBERATION OF LITHIUM FROM SUSTAINED-RELEASE PREPARATIONS - A COMPARISON OF 7 REGISTERED BRANDS, Pharmacopsychiatry, 27(1), 1994, pp. 27-31
Citation: J. Volke et H. Oelschlager, ELECTROANALYSIS OF B-TETRAHYDROOXAZOLO[3,2][1,4]-BENZODIAZEPIN-6-(5H)(HALOXAZOLAM), Die Pharmazie, 49(11), 1994, pp. 824-828